Benzinga's Top Upgrades, Downgrades For November 19, 2020

Upgrades

According to MKM Partners, the prior rating for Target Corp TGT was changed from Sell to Neutral. Target earned $2.79 in the third quarter, compared to $1.36 in the year-ago quarter. The stock has a 52-week-high of 172.1217 and a 52-week-low of 90.17. At the end of the last trading period, Target closed at $166.88.
Citigroup upgraded the previous rating for Coty Inc COTY from Neutral to Buy. In the first quarter, Coty showed an EPS of $0.02, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of 13.01 and a 52-week-low of 2.65. Coty closed at $5.30 at the end of the last trading period.
For Cohen & Steers Inc CNS, B of A Securities upgraded the previous rating of Neutral to the current rating Buy. For the third quarter, Cohen & Steers had an EPS of $0.67, compared to year-ago quarter EPS of $0.65. At the moment, the stock has a 52-week-high of 78.23 and a 52-week-low of 33.52. Cohen & Steers closed at $67.00 at the end of the last trading period.
For Intercontinental Exchange Inc ICE, Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. In the third quarter, Intercontinental Exchange showed an EPS of $1.03, compared to $1.06 from the year-ago quarter. The stock has a 52-week-high of 106.99 and a 52-week-low of 63.51. At the end of the last trading period, Intercontinental Exchange closed at $99.51.
For ZoomInfo Technologies Inc ZI, Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Interestingly, in the third quarter, ZoomInfo Technologies's EPS was $0.11. The stock has a 52-week-high of 64.4 and a 52-week-low of 30.83. At the end of the last trading period, ZoomInfo Technologies closed at $39.59.
Keefe, Bruyette & Woods upgraded the previous rating for State Street Corporation STT from Market Perform to Outperform. State Street earned $1.45 in the third quarter, compared to $1.51 in the year-ago quarter. The stock has a 52-week-high of 85.89 and a 52-week-low of 42.1. At the end of the last trading period, State Street closed at $69.18.
Jefferies upgraded the previous rating for Shopify Inc SHOP from Hold to Buy. For the third quarter, Shopify had an EPS of $1.13, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of 1146.91 and a 52-week-low of 305.3001. Shopify closed at $931.43 at the end of the last trading period.
Jefferies upgraded the previous rating for L Brands Inc LB from Underperform to Hold. In the third quarter, L Brands showed an EPS of $1.13, compared to $0.02 from the year-ago quarter. The current stock performance of L Brands shows a 52-week-high of 35.92 and a 52-week-low of 8.0. Moreover, at the end of the last trading period, the closing price was at $33.69.
Credit Suisse upgraded the previous rating for International Game Technology PLC IGT from Underperform to Neutral. In the third quarter, Intl Game Tech showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.84 and a 52-week-low of 3.59. Intl Game Tech closed at $12.07 at the end of the last trading period.
According to RBC Capital, the prior rating for GoodRx Holdings Inc GDRX was changed from Sector Perform to Outperform. Interestingly, in the third quarter, GoodRx Holdings's EPS was $0.09. The current stock performance of GoodRx Holdings shows a 52-week-high of 64.2185 and a 52-week-low of 33.51. Moreover, at the end of the last trading period, the closing price was at $33.76.
For Cree Inc CREE, JP Morgan upgraded the previous rating of Neutral to the current rating Overweight. For the first quarter, Cree had an EPS of $0.19, compared to year-ago quarter EPS of $0.03. The current stock performance of Cree shows a 52-week-high of 77.19 and a 52-week-low of 27.77. Moreover, at the end of the last trading period, the closing price was at $72.61.
Keefe, Bruyette & Woods upgraded the previous rating for Citigroup Inc C from Market Perform to Outperform. At the moment, the stock has a 52-week-high of 83.11 and a 52-week-low of 32.0. Citigroup closed at $51.05 at the end of the last trading period.
According to Stifel, the prior rating for AZZ Inc AZZ was changed from Hold to Buy. For the second quarter, AZZ had an EPS of $0.49, compared to year-ago quarter EPS of $0.54. The stock has a 52-week-high of 49.46 and a 52-week-low of 19.31. At the end of the last trading period, AZZ closed at $39.78.

Downgrades

B of A Securities downgraded the previous rating for T. Rowe Price Group Inc TROW from Buy to Neutral. T. Rowe Price Group earned $2.55 in the third quarter, compared to $2.13 in the year-ago quarter. The stock has a 52-week-high of 148.88 and a 52-week-low of 82.51. At the end of the last trading period, T. Rowe Price Group closed at $139.79.
Mizuho downgraded the previous rating for Portland General Electric Co POR from Buy to Neutral. For the third quarter, Portland General Electric had an EPS of $0.19, compared to year-ago quarter EPS of $0.61. At the moment, the stock has a 52-week-high of 63.08 and a 52-week-low of 31.96. Portland General Electric closed at $42.41 at the end of the last trading period.
Loop Capital downgraded the previous rating for Cinemark Holdings Inc CNK from Buy to Hold. Cinemark Hldgs earned $1.25 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of 35.74 and a 52-week-low of 5.71. Cinemark Hldgs closed at $14.90 at the end of the last trading period.
Credit Suisse downgraded the previous rating for Robert Half International Inc RHI from Neutral to Underperform. For the third quarter, Robert Half International had an EPS of $0.67, compared to year-ago quarter EPS of $1.01. The stock has a 52-week-high of 66.78 and a 52-week-low of 32.38. At the end of the last trading period, Robert Half International closed at $65.35.
For JPMorgan Chase & Co JPM, Keefe, Bruyette & Woods downgraded the previous rating of Outperform to the current rating Market Perform. For the third quarter, JPMorgan Chase had an EPS of $2.92, compared to year-ago quarter EPS of $2.68. The stock has a 52-week-high of 141.1 and a 52-week-low of 76.91. At the end of the last trading period, JPMorgan Chase closed at $115.24.
JP Morgan downgraded the previous rating for FuelCell Energy Inc FCEL from Overweight to Neutral. The stock has a 52-week-high of 5.8 and a 52-week-low of 0.4759. At the end of the last trading period, FuelCell Energy closed at $5.10.
For Foundation Building Materials Inc FBM, Truist Securities downgraded the previous rating of Buy to the current rating Hold. Foundation Building earned $0.31 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of 21.62 and a 52-week-low of 7.99. At the end of the last trading period, Foundation Building closed at $19.18.
Canaccord Genuity downgraded the previous rating for Cubic Corp CUB from Buy to Hold. For the fourth quarter, Cubic had an EPS of $2.82, compared to year-ago quarter EPS of $1.86. The stock has a 52-week-high of 74.11 and a 52-week-low of 30.86. At the end of the last trading period, Cubic closed at $64.78.
Keefe, Bruyette & Woods downgraded the previous rating for Bank of New York Mellon Corp BK from Outperform to Market Perform. Bank of New York Mellon earned $0.98 in the third quarter, compared to $1.07 in the year-ago quarter. The current stock performance of Bank of New York Mellon shows a 52-week-high of 51.6 and a 52-week-low of 26.4. Moreover, at the end of the last trading period, the closing price was at $38.73.

Initiations

With a current rating of Buy, Berenberg initiated coverage on The Trade Desk Inc TTD. The price target seems to have been set at $903.00 for Trade Desk. In the third quarter, Trade Desk showed an EPS of $1.27, compared to $0.75 from the year-ago quarter. The stock has a 52-week-high of 847.5 and a 52-week-low of 136.0. At the end of the last trading period, Trade Desk closed at $772.42.
Roth Capital initiated coverage on Perion Network Ltd PERI with a Buy rating. The price target for Perion Network is set to $10.75. In the third quarter, Perion Network showed an EPS of $0.21, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of 9.7 and a 52-week-low of 3.43. At the end of the last trading period, Perion Network closed at $7.56.
With a current rating of Overweight, Piper Sandler initiated coverage on NextEra Energy Inc NEE. The price target seems to have been set at $81.00 for NextEra Energy. For the third quarter, NextEra Energy had an EPS of $2.66, compared to year-ago quarter EPS of $2.39. The stock has a 52-week-high of 1232.24 and a 52-week-low of 72.5. At the end of the last trading period, NextEra Energy closed at $75.77.
Berenberg initiated coverage on FuboTV Inc FUBO with a Buy rating. The price target for FuboTV is set to $28.00. In the third quarter, FuboTV showed an EPS of $1.65, compared to $0.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of 23.8799 and a 52-week-low of 8.12. FuboTV closed at $20.88 at the end of the last trading period.
Goldman Sachs initiated coverage on Cognizant Technology Solutions Corp CTSH with a Buy rating. The price target for Cognizant Tech Solns is set to $90.00. Cognizant Tech Solns earned $0.97 in the third quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Cognizant Tech Solns shows a 52-week-high of 78.47 and a 52-week-low of 40.01. Moreover, at the end of the last trading period, the closing price was at $74.70.
With a current rating of Neutral, Goldman Sachs initiated coverage on Black Knight Inc BKI. The price target seems to have been set at $103.00 for Black Knight. For the third quarter, Black Knight had an EPS of $0.52, compared to year-ago quarter EPS of $0.51. At the moment, the stock has a 52-week-high of 97.19 and a 52-week-low of 50.01. Black Knight closed at $94.03 at the end of the last trading period.
With a current rating of Buy, Citigroup initiated coverage on Arrowhead Pharmaceuticals Inc ARWR. The price target seems to have been set at $90.00 for Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals earned $0.13 in the third quarter, compared to $0.21 in the year-ago quarter. The current stock performance of Arrowhead Pharmaceuticals shows a 52-week-high of 73.72 and a 52-week-low of 19.5101. Moreover, at the end of the last trading period, the closing price was at $68.36.
Goldman Sachs initiated coverage on Accenture PLC ACN with a Buy rating. The price target for Accenture is set to $278.00. Accenture earned $1.70 in the fourth quarter, compared to $1.74 in the year-ago quarter. The stock has a 52-week-high of 248.0 and a 52-week-low of 137.152. At the end of the last trading period, Accenture closed at $239.70.
Baird initiated coverage on Nurix Therapeutics Inc NRIX with an Outperform rating. The price target for Nurix Therapeutics is set to $40.00. In the third quarter, Nurix Therapeutics showed an EPS of $0.59, compared to $0.66 from the year-ago quarter. The current stock performance of Nurix Therapeutics shows a 52-week-high of 37.46 and a 52-week-low of 15.21. Moreover, at the end of the last trading period, the closing price was at $34.17.
With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Forma Therapeutics Holdings Inc FMTX. The price target seems to have been set at $61.00 for Forma Therapeutics Hldgs. Forma Therapeutics Hldgs earned $0.67 in the third quarter. The current stock performance of Forma Therapeutics Hldgs shows a 52-week-high of 52.7499 and a 52-week-low of 31.45. Moreover, at the end of the last trading period, the closing price was at $38.32.
SMBC Nikko initiated coverage on Arena Pharmaceuticals Inc ARNA with an Outperform rating. The price target for Arena Pharmaceuticals is set to $100.00. In the third quarter, Arena Pharmaceuticals showed an EPS of $1.69, compared to $1.46 from the year-ago quarter. The current stock performance of Arena Pharmaceuticals shows a 52-week-high of 90.19 and a 52-week-low of 32.95. Moreover, at the end of the last trading period, the closing price was at $63.85.
Needham initiated coverage on Apellis Pharmaceuticals Inc APLS with a Buy rating. The price target for Apellis Pharmaceuticals is set to $59.00. In the third quarter, Apellis Pharmaceuticals showed an EPS of $1.79, compared to $1.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of 45.04 and a 52-week-low of 16.85. Apellis Pharmaceuticals closed at $41.58 at the end of the last trading period.